<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01594060</url>
  </required_header>
  <id_info>
    <org_study_id>0042-12-EMC</org_study_id>
    <nct_id>NCT01594060</nct_id>
  </id_info>
  <brief_title>Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical Wards</brief_title>
  <official_title>A Randomized, Comparative Study of Basal-bolus Insulin Versus Conventional Sliding-scale Regular Insulin Therapy in Management of Non-critically Ill Patients Hospitalized in the Medical Ward.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A comparison of two treatment approaches for hyperglycemia in diabetic patients hospitalized&#xD;
      in the medical department. The first approach is called basal-bolus in which 4 insulin shots&#xD;
      are given daily ( 3 short acting before meals and one long acting before bed time). The&#xD;
      second approach is called sliding scale in which short acting insulin alone is given before&#xD;
      meals and before bed time according to the patient's glucose values. The aim is to keep&#xD;
      fasting glucose between 140-180 mg/dl.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Diabetes Mellitus Type 2</condition>
  <arm_group>
    <arm_group_label>sliding scale</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>basal bolus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin, regular - act rapid</intervention_name>
    <description>4 shots of regular insulin: 3 before meals and one at bedtime.</description>
    <arm_group_label>sliding scale</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin glulisine, Insulin glargine</intervention_name>
    <description>1 shot glargine at bedtime 3 shots glulisine before meals</description>
    <arm_group_label>basal bolus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients admitted to internal medicine ward with blood glucose (BG) between 140-400&#xD;
             mg/dl.&#xD;
&#xD;
          -  Known history (&gt;6months) of diabetes.&#xD;
&#xD;
          -  Aged 18-80 years old.&#xD;
&#xD;
          -  Previous therapy including either diet alone or any combination of oral hypoglycemia&#xD;
             agents, glucagon-like peptide 1 (GLP-1) analogs and long acting insulin analogs or&#xD;
             Neutral Protamine Hagedorn (NPH).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Patients with ketoacidosis&#xD;
&#xD;
          -  Patients with unknown history of diabetes&#xD;
&#xD;
          -  Patients with type 1 diabetes mellitus&#xD;
&#xD;
          -  Patients with clinically relevant hepatic disease or renal impairment ( serum&#xD;
             creatinineâ‰¥2.5 mg/dl)&#xD;
&#xD;
          -  Use of corticosteroid therapy&#xD;
&#xD;
          -  Patient with any mental disorder preventing him to cooperate and give informed&#xD;
             consent.&#xD;
&#xD;
          -  Patients on multiple daily doses of insulin regimen.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>May 7, 2012</study_first_submitted>
  <study_first_submitted_qc>May 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2012</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin Glargine</mesh_term>
    <mesh_term>Insulin glulisine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

